Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Front Cell Infect Microbiol ; 12: 895329, 2022.
Article in English | MEDLINE | ID: mdl-35770068

ABSTRACT

Background: Due to more attentions paid to melanized fungi over the past few decades and under the background of the global coronavirus disease 2019 pandemic (COVID-19) the fact that the virus itself and the immunosuppressive agents such as glucocorticoids can further increase the risk of infections of deep mycoses, the number of patients with phaeohyphomycosis (PHM) has a substantial increase. Their spectrum is broad and the early diagnosis and treatments are extremely sticky. This study aims to more comprehensively understand the clinical features of phaeohyphomycosis in China over 35 years and to establish a more applicable systematical classification and severity grades of lesions to guide treatments and prognosis. Methods: We reviewed 174 cases of proven phaeohyphomycosis reported in Chinese and English language literature from 1987 to 2021 and we also made the accurate classification definitions and detailed information about the epidemiology, species of clinical dematiaceous fungi, minimum inhibitory concentration values, clinical features, treatments, and prognosis. Results: The mortality of cerebral, disseminated and pulmonary phaeohyphomycosis are 55%, 36%, and 25%. Nearly 19% of patients had poor quality of life caused by the complications such as disability, disfigurements, and blindness. The overall misdiagnosis rate of phaeohyphomycosis was 74%. Moderate to severe rashes are accounting for 82% of subcutaneous phaeohyphomycosis. The areas of the head and face are mostly affected accounting for 16% of severe rashes. Nearly 30% of invasive infections of phaeohyphomycosis are triggered by recurrent lesions. Voriconazole, itraconazole, amphotericin B deoxycholate (AmB-DOC), and terbinafine were most commonly used but diagnosis and treatments of phaeohyphomycosis remain challenging in reality. Conclusions: Our classifications are likely to be more practical and easier to popularize, and there are still also plenty of characteristics in these non-specific lesions. There're no significant variations in cure rates, or death rates between three grades of lesions. But patients with severe rashes have longer courses and lower effective rates.


Subject(s)
COVID-19 , Phaeohyphomycosis , Antifungal Agents/therapeutic use , Fungi , Humans , Phaeohyphomycosis/diagnosis , Phaeohyphomycosis/drug therapy , Phaeohyphomycosis/epidemiology , Quality of Life , Voriconazole
2.
Mycopathologia ; 184(2): 309-313, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30666543

ABSTRACT

We report a case of eczema-like cutaneous mucormycosis caused by Rhizopus arrhizus. A 4-year-old child was presented to our hospital with a history of gradually enlarging papule and plaque in the periumbilical area for nearly 4 years since 2 weeks after his birth, and it has been misdiagnosed as eczema for nearly 3 years. Based on histopathology examination, the fungus culture test and DNA sequencing, it was revealed that R. arrhizus should be the responsible fungus for skin infection. The patient was successfully cured by combination of intravenous drip and percutaneous injection amphotericin B for nearly 3 months, and no recrudescence was seen during a follow-up of 6-month observation.


Subject(s)
Amphotericin B/administration & dosage , Antifungal Agents/administration & dosage , Dermatomycoses/diagnosis , Dermatomycoses/pathology , Mucormycosis/diagnosis , Mucormycosis/pathology , Rhizopus/isolation & purification , Child, Preschool , Dermatomycoses/drug therapy , Eczema/pathology , Histocytochemistry , Humans , Infusions, Intravenous , Injections , Male , Microbiological Techniques , Mucormycosis/drug therapy , Sequence Analysis, DNA , Treatment Outcome
3.
Mycopathologia ; 183(2): 445-449, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29086142

ABSTRACT

We report a case of primary cutaneous mucormycosis caused by Mucor irregularis. A 66-year-old man was presented to our hospital with a history of gradually enlarging plaque on the right leg for about a year. The identification of pathogen based on the fungus morphology and DNA sequencing revealed M. irregularis as the responsible fungus for skin lesion. The lesion was removed incidentally by a surgery procedure, and no recrudescence was seen during a follow-up of 24-month observation.


Subject(s)
Dermatomycoses/diagnosis , Dermatomycoses/surgery , Mucor/isolation & purification , Mucormycosis/diagnosis , Mucormycosis/surgery , Aged , Dermatomycoses/pathology , Histocytochemistry , Humans , Male , Microbiological Techniques , Microscopy , Mucor/classification , Mucor/cytology , Mucor/genetics , Mucormycosis/pathology , Sequence Analysis, DNA , Treatment Outcome
4.
Mycopathologia ; 176(1-2): 101-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23591621

ABSTRACT

We present the first case of phaeohyphomycosis caused by Rhinocladiella basitona (R. basitona) in China and describe the mycological characteristics of this pathogen. A 11-year-old girl was presented with plaque on her face for 3 years. Diagnosis was based on histopathology, mycology, and molecular identification. The patient was treated with terbinafine and itraconazole. This case is the second of phaeohyphomycosis caused by R. basitona in the world (previously belonging to Geniculosporium).


Subject(s)
Ascomycota/classification , Ascomycota/isolation & purification , Phaeohyphomycosis/diagnosis , Phaeohyphomycosis/microbiology , Antifungal Agents/therapeutic use , Child , China , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Face/pathology , Female , Histocytochemistry , Humans , Itraconazole/therapeutic use , Microbiological Techniques , Molecular Diagnostic Techniques , Molecular Sequence Data , Naphthalenes/therapeutic use , Phaeohyphomycosis/drug therapy , Phaeohyphomycosis/pathology , Sequence Analysis, DNA , Terbinafine
5.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 33(4): 371-4, 2011 Aug.
Article in Chinese | MEDLINE | ID: mdl-21906443

ABSTRACT

OBJECTIVE: To investigate whether Candida albicans-native phospholipomannan (PLM) induce an inflammation response through Toll-like receptor(TLRé2 in human acute monocytic leukemia cell line (THP-1) cells. METHODS: Human THP-1 monocytes were challenged with PLM in vitro. The mRNA expressions of TLR2, TLR4, proinflammatory cytokine [interleukin(IL)-6], and chemokine (IL-8) were assayed by real time reverse transcription polymerase chain reaction. The secretions of IL-6 and IL-8 were measured by enzyme-linked immunosorbent assay. The expression of TLR2 was analyzed with Western blot. RESULTS: PLM increased the mRNA expressions and secretions of proinflammatory cytokines (IL-6) and chemokines (IL-8) in THP-1 cells (all P=0.0000). PLM up-regulated the mRNA and protein levels of TLR2 (P=0.0000), whereas the mRNA level of TLR4 was not altered. PLM hydrolyzed with ß-D-mannoside manno hydrolase failed to induce gene and protein expressions of TLR2, IL-6, and IL-8. Anti-TLRS-neutralizing antibody blocked the PLM-induced secretions of IL-6 and IL-8 in THP-1 cells (P = 0.0003, P = 0.0010). CONCLUSION: Canidada albicans-native PLM may contribute to the inflammatory responses during Candida infection in a TLR2-dependent manner.


Subject(s)
Candida albicans/chemistry , Glycolipids/pharmacology , Interleukin-6/metabolism , Interleukin-8/metabolism , Monocytes/drug effects , Cells, Cultured , Humans , Monocytes/immunology , Monocytes/metabolism , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism
6.
Eur J Dermatol ; 21(1): 37-42, 2011.
Article in English | MEDLINE | ID: mdl-21245019

ABSTRACT

A rapid and reliable triplex PCR procedure was developed to detect pathogenic fungi directly from specimens of onychomycosis. One hundred and four patients were included in this study. Of them, forty-five (43.3%) were finally diagnosed with onychomycosis according to the diagnostic criteria. The sensitivity of PCR, microscopy and culture were 93.3%, 100% and 64.4%, respectively; the specificities were 100%, 86.4% and 100%, respectively; the positive predictive values were 100%, 84.9% and 100%, respectively; the negative predictive values were 95.2%, 100% and 78.7%, respectively. This molecular diagnostic process could distinguish the 3 groups of pathogens in onychomycosis (dermatophyte, yeast and mold) and could be completed within 8 h. This multiplex PCR assay could used in laboratories with no mycological specialization for rapid etiologic diagnosis and treatment selection, especially in suspected fungus cases if they can not be detected by conventional methods or if a rapid diagnosis of onychomycosis is needed.


Subject(s)
Onychomycosis/microbiology , Polymerase Chain Reaction/methods , Humans , Sensitivity and Specificity
7.
Med Mycol ; 47(6): 663-8, 2009.
Article in English | MEDLINE | ID: mdl-19301174

ABSTRACT

A slowly enlarging arm ulcer appeared in a 61-year-old man with cutaneous T cell lymphoma. Skin biopsy revealed aseptate hyphae and nodular small/medium-sized pleomorphic CD4(+) T cell infiltration. Cultures yielded Absidia corymbifera which was identified by phenotypic and molecular methods. Since a thorough examination did not detect organ involvement, the patient was diagnosed as having primary cutaneous zygomycosis. This is the first case report of cutaneous zygomycosis caused by A. corymbifera in a patient with primary cutaneous CD4(+) small/medium-sized pleomorphic T-cell lymphoma. Other cases of primary cutaneous zygomycosis caused by A. corymbifera are also reviewed.


Subject(s)
Absidia/isolation & purification , Lymphoma, T-Cell, Cutaneous/complications , Zygomycosis/complications , Zygomycosis/diagnosis , Absidia/cytology , Absidia/genetics , Arm/microbiology , Arm/pathology , DNA, Fungal/analysis , Humans , Immunohistochemistry , Male , Microbial Sensitivity Tests , Middle Aged , Polymerase Chain Reaction , Ulcer/microbiology , Ulcer/pathology , Zygomycosis/microbiology , Zygomycosis/pathology
8.
Eur J Dermatol ; 19(1): 34-7, 2009.
Article in English | MEDLINE | ID: mdl-19059826

ABSTRACT

A new medium (DBM) was compared with dermatophyte test medium (DTM) for the diagnosis of dermatophyte infection. The sensitivity was 103 cfu/mL (2 x 101 cfu/slant) for both DTM and DBM with a suspension of Trichophyton rubrum. In axenic cultures, all dermatophytes tested altered the color of both media. Although most non dermatophytic molds made a color change, it was at a slower rate. In nail samples of dermatophyte infection, all dermatophytes altered the color of both media. However, the time for discoloration was shorter with DBM than with DTM (5.83 +/- 0.39 days vs. 7.32 +/- 0.41 days, t = 2.63, P = 0.01). Most isolates of nondermatophyte also made a discoloration, but they could be distinguished from dermatophytes by their colonial diameters when the color began to change (> or = 5 mm). Our results were in good agreement with a professional laboratory of medical mycology, however, the latter is regularly able to differentiate exactly the species of the growing dermatophyte. The DBM medium is more convenient, rapid, more accurate and economical to use than DTM.


Subject(s)
Arthrodermataceae/classification , Dermatomycoses/diagnosis , Mycological Typing Techniques/methods , Analysis of Variance , Chi-Square Distribution , Culture Media , Humans , Indicators and Reagents , Onychomycosis/diagnosis , Predictive Value of Tests , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...